ArticleAnnals of nuclear medicine2024
Novel technetium-99m-labeled bivalent PSMA-targeting probe based on hydroxamamide chelate for diagnosis of prostate cancer.
Yoichi Shimizu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it